Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy

BACKGROUND: Infliximab therapy in patients with Crohn’s disease decreases resource use; however, the overall impact on health-related expenditures is unclear, especially beyond one year of study.

Bibliographic Details
Main Authors:	Dustin E Loomes, Christopher Teshima, Philip Jacobs, Richard Fedorak
Format:	Article
Language:	English
Published:	Hindawi Limited 2011-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/2011/157604

id	doaj-a69ddb9bb80045b9b3dc51fcfee4a69f
record_format	Article
spelling	doaj-a69ddb9bb80045b9b3dc51fcfee4a69f2020-11-24T22:30:28ZengHindawi LimitedCanadian Journal of Gastroenterology0835-79002011-01-0125949750210.1155/2011/157604Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab TherapyDustin E Loomes0Christopher Teshima1Philip Jacobs2Richard Fedorak3Division of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaBACKGROUND: Infliximab therapy in patients with Crohn’s disease decreases resource use; however, the overall impact on health-related expenditures is unclear, especially beyond one year of study.http://dx.doi.org/10.1155/2011/157604
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Dustin E Loomes Christopher Teshima Philip Jacobs Richard Fedorak
spellingShingle	Dustin E Loomes Christopher Teshima Philip Jacobs Richard Fedorak Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy Canadian Journal of Gastroenterology
author_facet	Dustin E Loomes Christopher Teshima Philip Jacobs Richard Fedorak
author_sort	Dustin E Loomes
title	Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy
title_short	Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy
title_full	Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy
title_fullStr	Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy
title_full_unstemmed	Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy
title_sort	health care resource use and costs for crohn’s disease before and after infliximab therapy
publisher	Hindawi Limited
series	Canadian Journal of Gastroenterology
issn	0835-7900
publishDate	2011-01-01
description	BACKGROUND: Infliximab therapy in patients with Crohn’s disease decreases resource use; however, the overall impact on health-related expenditures is unclear, especially beyond one year of study.
url	http://dx.doi.org/10.1155/2011/157604
work_keys_str_mv	AT dustineloomes healthcareresourceuseandcostsforcrohnsdiseasebeforeandafterinfliximabtherapy AT christopherteshima healthcareresourceuseandcostsforcrohnsdiseasebeforeandafterinfliximabtherapy AT philipjacobs healthcareresourceuseandcostsforcrohnsdiseasebeforeandafterinfliximabtherapy AT richardfedorak healthcareresourceuseandcostsforcrohnsdiseasebeforeandafterinfliximabtherapy
_version_	1725740844357517312

Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy

Similar Items